ORGO PEER ANALYSIS

Organogenesis Holdings Inc — metric-by-metric comparison with peers and the industry median

ORGOOrganogenesis Holdings Inc

🇺🇸 USA · NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Value it Duel

Overall Profile & Returns

· Drug Manufacturers - Specialty & Generic

Position Within Industry

0 = weak quartile, 100 = strong quartile

ORGOIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	ORGO	DEVA	TLRY	HLN	GENIL	ECILC	Ind. Median
P/E	—	—	—	30.79●	46.82	—	21.35
P/B	0.83	0.51	0.32●	1.94	3.47	0.80	1.77
EV/EBITDA	7.93	6.74●	—	18.90	14.07	33.84	12.18
P/S	0.62	0.70	0.58●	3.87	1.86	5.03	2.08

Financial Health
Metric	ORGO	DEVA	TLRY	HLN	GENIL	ECILC	Ind. Median
Current Ratio	3.53●	2.00	2.79	0.92	1.33	1.73	2.22
Debt/Equity	18.6%	23.1%	20.4%	52.3%	41.0%	5.9%●	46.3%
NetDebt/EBITDA	-0.57●	0.89	-0.07	3.50	1.10	-0.10	1.24

Profitability
Metric	ORGO	DEVA	TLRY	HLN	GENIL	ECILC	Ind. Median
Net Margin	-0.1%	-4.4%	-158.8%	12.6%●	4.0%	-3.6%	4.0%
ROE	-0.1%	-3.6%	-63.6%	6.3%	8.7%●	-0.6%	6.4%
ROA	-0.1%	-2.5%	-49.7%	3.2%	4.8%●	-0.5%	3.4%
EBITDA Margin	7.3%	12.0%	-156.2%	25.2%●	14.3%	14.8%	18.2%

Growth + Dividend
Metric	ORGO	DEVA	TLRY	HLN	GENIL	ECILC	Ind. Median
Rev. Growth	11.9%	7.7%	3.8%	-26.7%	16.3%●	-2.3%	7.5%
NI Growth	—	—	—	-14.2%	146.6%●	—	5.0%
Div. Yield	3.7%●	0.0%	—	2.0%	0.0%	2.6%	2.0%
Payout	-4,093.3%	0.0%	—	40.0%	0.0%	-365.1%	0.8%

Valuation
Metric	ORGO	SIGA	ANIK	EOLS	EBS	ASRT	Ind. Median
P/E	—	13.26	—	—	—	—	21.35
P/B	0.83	1.77	1.62	-15.83●	0.88	2.00	1.77
EV/EBITDA	7.93	4.50●	—	—	5.67	—	12.18
P/S	0.62●	2.87	1.87	1.51	0.68	1.48	2.08

Financial Health
Metric	ORGO	SIGA	ANIK	EOLS	EBS	ASRT	Ind. Median
Current Ratio	3.53	3.25	4.46●	2.04	4.29	1.82	2.22
Debt/Equity	18.6%	0.4%	19.2%	-573.0%●	109.7%	53.3%	46.3%
NetDebt/EBITDA	-0.57	-5.27	3.30	-8.20●	2.68	5.39	1.24

Profitability
Metric	ORGO	SIGA	ANIK	EOLS	EBS	ASRT	Ind. Median
Net Margin	-0.1%	21.6%●	-9.5%	-14.4%	-1.3%	-34.9%	4.0%
ROE	-0.1%	11.0%●	-7.8%	—	-1.6%	-38.8%	6.4%
ROA	-0.1%	8.7%●	-6.0%	-20.0%	-0.6%	-14.3%	3.4%
EBITDA Margin	7.3%	29.3%●	-4.0%	-4.6%	22.8%	-5.7%	18.2%

Growth + Dividend
Metric	ORGO	SIGA	ANIK	EOLS	EBS	ASRT	Ind. Median
Rev. Growth	11.9%	-22.1%	23.2%●	9.6%	-29.9%	-14.2%	7.5%
NI Growth	—	-58.2%	—	—	—	—	5.0%
Div. Yield	3.7%	16.1%●	—	—	—	—	2.0%
Payout	-4,093.3%	213.6%	—	—	—	—	0.8%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on ORGO

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.